English edition Community care · Italy
From an Italian pharmacy to follow-up care
A community test has a useful endpoint when the person tested knows what happens next. This proposed Italian pathway links the pharmacy, the general practitioner and the laboratory.
Agree the scope before inviting people
Italy’s Legislative Decree 153/2009 sets out pharmacy services, including provisions on first-line self-testing and on pharmacist-performed tests using capillary blood. The Ministerial Decree of 16 December 2010 addresses the conditions for first-line self-testing. These provisions cover different activities. A team planning a service should identify the applicable provision, regional arrangements, professional responsibilities and the device’s intended use for the particular test.
The example below is an organisational proposal. It describes an Italian setting and does not establish a standard of pharmacy practice in other countries.
Assign a recipient to each result
Before testing, explain the question being asked, the limits of the result and how the person can obtain follow-up. The pharmacy records the sample, device, operator and any quality issue according to the agreed procedure. An abnormal or uninterpretable result needs an identifiable recipient and an appropriate time frame for communication.
The general practitioner considers the clinical history and decides whether further assessment or laboratory testing is indicated. The laboratory provides the agreed confirmatory examination or technical advice on method and specimen. For a potentially urgent finding, the site uses its urgent referral pathway without waiting for a routine appointment.
Count completed follow-up
A service that counts only tests performed cannot tell how many people received appropriate follow-up. For an agreed reporting period, identify how many participants were referred, how many had a documented outcome and how many could not be reached. Use the number referred as the denominator when reporting follow-up completion.
An unrecorded outcome is a gap in the pathway. It should be kept separate from a normal clinical finding and assigned to a team member for follow-up under the service’s data-sharing arrangements.
Design the handover before the first test, including who receives the finding, within what time and how completion is recorded.